Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate

Journal of Virology

Volumn 75, Issue 8, 2001, Pages 3568-3580

  Martin J ^a   LaBranche, C C ^a   Gonzalez Scarano F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; ENVELOPE GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; HUMORAL IMMUNITY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADAPTATION, BIOLOGICAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BRAIN; CELL LINE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENES, REPORTER; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNE SERA; LUCIFERASES; MICROGLIA; NEUTRALIZATION TESTS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; SERIAL PASSAGE; TRANSFECTION;

EID: 0035078794     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.8.3568-3580.2001     Document Type: Article

References (118)

1. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates
2. HIV-1 infection of cultured human adult oligodendrocytes
3. CC chemokine receptor 5-mediated signaling and HIV-1 coreceptor activity share common structural determinants: Critical residues in the third extracellular loop support HIV-1 fusion
4. CC-CKR5: A RANTES, MIP-1α and MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
5. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
6. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
7. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry
8. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses
9. A new classification for HIV-1
10. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
11. HIV-1-induced cell fusion is mediated by multiple regions within the viral envelope and the CCR-5 co-receptor
12. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
13. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 env protein
14. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism
15. The relationship between AIDS dementia complex and the presence of macrophage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid
16. Neuropathology of human immunodeficiency virus infection
17. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein
18. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells
19. Acute encephalopathy coincident with seroconversion for anti-HTLV-III
20. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection
21. SF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
22. Distinct biological and serological properties of human immunodeficiency virus from the brain
23. The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
24. + T cells during primary HIV-1 infection
25. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
26. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
27. Early viral brain invasion in iatrogenic human immunodeficiency virus infection
28. Identification of a major co-receptor for primary isolates of HIV-1
29. Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: Examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease
30. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusin cofactors
31. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
32. + cells is mediated by the chemokine receptor CC-CKR-5
33. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
34. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
35. Spontaneous mutations in the env gene of human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype
36. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains
37. HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies
38. A tyrosinerich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
39. + T cells provides a mechanism for livelong persistence of HIV-1, even in patients on effective combination therapy
40. Chemokine receptors in HIV-1 infection of the central nervous system
41. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
42. Clinical-neuropathological correlation in HIV-associated dementia
43. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
44. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
45. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
46. Long-term productive human immunodeficiency virus-1 infection in human infant microgila
47. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
48. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
49. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein in infection of primary macrophages and soluble CD4 neutralization
50. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication
51. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences
52. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
53. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity
54. Packaging system for rapid production of murine leukemia virus vectors with variable tropism
55. Chemokine receptors in the human brain and their relationship to HIV infection
56. Epitope mapping of CCR5 reveals multiple conformational states and distinct overlapping structures involved in chemokine and coreceptor function
57. Productive infection of human fetal microglia by HIV-1
58. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1
59. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
60. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured brain tissue: Identification of replication-competent and defective viral genomes
61. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
62. Dementia associated with the acquired immunodeficiency syndrome
63. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies
64. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
65. Neuropathological changes in early HIV-1 dementia
66. Interactions among HIV gp120, CD4, and CXCR4: Dependence on CD4 expression levels, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies
67. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage
68. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
69. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
70. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies
71. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages
72. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism
73. Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4
74. Functional characterization of the V1V2 region of human immunodeficiency virus type 1
75. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion
76. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
77. Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1
78. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
79. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence
80. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences
81. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differ between demented and nondemented AIDS patients
82. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex
83. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1
84. A role for carbohydrates in immune evasion in AIDS
85. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
86. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates
87. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
88. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: Soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120
89. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
90. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding
91. Pathology of HIV-1 infection of the central nervous system. A review
92. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia
93. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: Role of the V1/V2 domains
94. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1
95. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: Evidence of differential tropism
96. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies
97. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization
98. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody
99. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
100. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread
101. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR5
102. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120
103. Specific tropism of HIV-1 for microglial cells in primary human brain cultures
104. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion
105. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome
106. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients
107. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
108. Adaptation to persistent growh in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
109. CD4-induced interaction of primary HIV-1 glycoproteins with the chemokine receptor CCR-5
110. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
111. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
112. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: Role of glycosylation in the correct folding of the V1/V2 domain
113. The antigenic structure of the HIV gp120 envelope glycoprotein
114. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding
115. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
116. Culture of glial cells from human brain biopsies
117. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
118. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic